Narrative review / 2014
Functional foods with plant sterols or stanols at 2 g/day lower LDL-C by 8% to 10% without adverse signals, but lack hard cardiovascular endpoint trial data.
An EAS Consensus Panel reviewed evidence on functional foods with added plant sterols and/or plant stanols for reducing plasma LDL-C and cardiovascular risk. Intakes of 2 g/day inhibited cholesterol absorption, reduced LDL-C by 8-10%, provided an effect additive to statins equivalent to doubling the statin dose, and lowered plasma triglycerides by 6-9% in hypertriglyceridaemic patients. Plant sterol/stanol levels at this intake were not linked to adverse health effects in long-term human studies. The panel noted that no randomized controlled clinical trials with hard clinical endpoints currently exist.
- Study type
- Consensus panel review
- Who was studied
- Individuals with dyslipidaemia, hypercholesterolaemia, or cardiovascular risk
- What was measured
- LDL-C reduction, cardiovascular risk, plasma plant sterol/stanol levels, safety
THE PAPER
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.
Gylling H, Plat J, Turley S, Ginsberg HN, Ellegård L, Jessup W, Jones PJ, Lütjohann D, Maerz W, Masana L, Silbernagel G, Staels B, Borén J, Catapano AL, De Backer G, Deanfield J, Descamps OS, Kovanen PT, Riccardi G, Tokgözoglu L, Chapman MJ, European Atherosclerosis Society Consensus Panel on Phytosterols. Atherosclerosis, 2014.
PubMed 24468148 ↗DOI 10.1016/j.atherosclerosis.2013.11.043 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.